Description: Advanced Oncotherapy Plc is focused on providing radiotherapy systems for cancer treatment through the use of a proton therapy technology. The Company is engaged in development and then building of the Linac Image Guided Hadron Technology (LIGHT) proton beam cancer therapy device and management of healthcare related property. The Company's segments include Development of Proton Therapy-UK; Development of Proton Therapy-Switzerland; Development of Proton Therapy-USA, and Healthcare-related properties-UK. Its LIGHT system uses accelerators, which is a series of modular units. This feature offers hospitals and centers to customize treatment plans based on a range of energies. The Company's Research and development/ADAM S.A. (R&D/ADAM) facility is located on the campus of European Council for Nuclear Research (CERN), Geneva, Switzerland, and a manufacturing plant, clinical research and clinician training facility in Syracuse, the United States.
Home Page: www.avoplc.com
AVO Technical Analysis
4 Tenterden Street
London,
W1S 1TE
United Kingdom
Phone:
44 20 3617 8728
Officers
Name | Title |
---|---|
Dr. Michael Jeffrey Sinclair | Exec. Chairman |
Mr. Nicolas Serandour | CEO & Exec. Director |
Prof. Stephen Myers OBE | Exec. Director |
Mr. Ed Lee | COO & Pres of Europe |
Mr. Graham Pughe | Sr. Vice-Pres of Accounting |
Ms. Berengere Pons-Chabord | Sr. Vice-Pres of Corp. Fin. |
Dr. Manuel Gallas | Director of Technical & Engineering |
Mr. David Navas | VP of Investor and PR |
Ms. Bridget Biggar | Director of HR |
Ms. Donatella Ungaro | Managing Director of ADAM |
Exchange: LSE
Country: UK
Currency: Pence sterling (p)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Providers & Services |
GIC Sub-Industry: | Health Care Services |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 1.4709 |
Price-to-Sales TTM: | 0 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 174 |